Factors affecting physician decision-making regarding antiplatelet therapy in minor ischemic stroke.

ABSTRACT:

Purpose

To identify the most important factors affecting physician decision-making regarding antiplatelet therapy.

Methods

We retrospectively gathered data from minor ischemic stroke patients with NIHSS scores ≤ 5 within 72 h of onset from 2010 to 2018. The population was divided into four groups by initial antiplatelet therapy: aspirin monotherapy (AM), dual antiplatelet therapy with aspirin and a loading dose of clopidogrel (clopidogrel loading dose of 300 mg on the first day; DAPT-ALC), dual antiplatelet therapy with aspirin and no loading dose of clopidogrel (clopidogrel 75 mg daily, no loading dose; DAPT-AUC), and clopidogrel monotherapy (CM).

Results

In total, 1,377 patients were included in the analysis (excluding patients who accepted thrombolytic drugs, parti

SUBMITTER: Liu T 

PROVIDER: S-EPMC9477012 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature